Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy. [electronic resource]
Producer: 20100824Description: e232-4 p. digitalISSN:- 1873-5835
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- Combined Modality Therapy
- Humans
- Immunotherapy
- Job Syndrome -- complications
- Lymphoma, Large B-Cell, Diffuse -- complications
- Male
- Rituximab
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.